Multicenter outcomes for ventricular assist device support for failed stage II palliation
Ventricular assist device (VAD) use for failed stage II palliation (S2P) is increasing with limited data on outcomes.
Berlin Heart EXCOR®
Impact of HeartWare VAD discontinuation on the pediatric population: An ACTION registry analysis
The HeartWare ventricular assist device (HVAD) was discontinued in July 2021. The study aims to describe the impact the discontinuation the HVAD had on pediatric ventricular assist device (VAD) utilization and outcomes.
First Pediatric Cardiac Device IDE Trial (Berlin Heart EXCOR® Active Driver) has Completed Enrollment Using the ACTION Registry
ACTION, in conjunction with Berlin Heart, Inc., launched the first prospective FDA regulated device trial using a pediatric ventricular assist device (VAD) registry in November 2022. Enrollment in the trial has been completed as of August 11, 2023, just 10 months after launch.
ACTION Fall ’23 Meeting: Plan to Practice Our Role in Clinical Trials
Join us a day before the VAD summit for our ACTION Fall 2023 Meeting. We will be focusing on our role in clinical trials for the larger meeting, with shorter meeting to follow for the Berlin Heart Active Driver Trial PIs.
ACTION Fall ’23 Meeting: Plan to Practice Our Role in Clinical Trials Read More »
Berlin Heart EXCOR® Active OPS
Check out the newest One Page Summary (OPS) featuring the Berlin Heart EXCOR® Active This OPS includes an overview of the device pump settings, system preferences, pump optimization, power sources, accessories, alarms
Berlin Heart EXCOR® Active OPS Read More »
International Pediatric VAD and Heart Failure Summit 2023
The Heart Center at St. Louis Children’s Hospital and Washington University School of Medicine, invite you to the return of the International Pediatric VAD and Heart Failure Summit.
International Pediatric VAD and Heart Failure Summit 2023 Read More »
Berlin Heart OPS
Check out the Berlin Heart One Page Summary (OPS). This OPS includes pump settings and function, cannulation strategies, blood pump and system components, power sources, as well as highlighting anticoagulation,
Prospective Trials Using a Registry as the Platform
The ACTION registry is being used to conduct prospective trials. Currently the Berlin Active Driver is being studied at 20 ACTION sites.
Prospective Trials Using a Registry as the Platform Read More »
Finding Light in the Dark: Brynn’s Story
One weekend, Jimmie noticed his 16-month-old daughter, Brynn, was breathing strangely. One week later, Brynn was heading into surgery to be placed on a VAD. For half a year, Jimmie and his wife, Kristyn, waited by the phone for the transplant call. The family had many long nights, learned how to navigate their lives with a VAD, and finally reached the end of a dark tunnel.
Finding Light in the Dark: Brynn’s Story Read More »
Berlin Heart EXCOR and ACTION Post-Approval Surveillance Study Report
Cerebrovascular accidents (CVA) are a common problem in pediatric VAD support. This Pedimacs analysis investigates rates, risk factors, and outcomes The field of pediatric mechanical circulatory support changed dramatically when
Berlin Heart EXCOR and ACTION Post-Approval Surveillance Study Report Read More »
